Carroll Financial Associates’s Imunon IMNN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$0 Sell
1
-1
-50% -$156 ﹤0.01% 1768
2021
Q3
$0 Buy
+2
New +$415 ﹤0.01% 1839
2021
Q2
Hold
0
1760
2021
Q1
Hold
0
1687
2020
Q4
Hold
0
1585
2020
Q3
Hold
0
1576
2020
Q2
Hold
0
1596
2020
Q1
Hold
0
1551
2019
Q4
Hold
0
1605
2019
Q3
Hold
0
1608
2019
Q2
Hold
0
1630
2019
Q1
Hold
0
1420
2018
Q4
Hold
0
1330
2018
Q3
Hold
0
1324
2018
Q2
Hold
0
1287
2018
Q1
Hold
0
1283
2017
Q4
Hold
0
1256
2017
Q3
Hold
0
1220
2017
Q2
Hold
0
1208
2017
Q1
Hold
0
1197
2016
Q4
Hold
0
1174
2016
Q3
Hold
0
1172
2016
Q2
Hold
0
1169
2016
Q1
Hold
0
1162
2015
Q4
Hold
0
1042
2015
Q3
Hold
0
1020
2015
Q2
Hold
0
1019
2015
Q1
Hold
0
728
2014
Q4
Hold
0
694
2014
Q3
Hold
0
784
2014
Q2
Hold
0
815
2014
Q1
Hold
0
-$2K 895
2013
Q4
Hold
0
721
2013
Q3
Hold
0
692
2013
Q2
Hold
0
543

Other funds holding IMNN

Carroll Financial Associates's IMNN Position: Q4 2021 in Review

Carroll Financial Associates reduced its Imunon (IMNN) stake by 50% in Q4 2021, selling an estimated $156 and leaving 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1768.

Carroll Financial Associates first reported a position in IMNN in Q3 2021 and has held it in 2 quarters since. 37 funds tracked by Wall St. Rank hold IMNN as of Q4 2021.

  • Carroll Financial Associates held 1 share of Imunon worth $0 as of Q4 2021.
  • Carroll Financial Associates sold 1 Imunon share in Q4 2021, an estimated $156.
  • Imunon made up ﹤0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #1768 holding.
  • Carroll Financial Associates first reported a position in Imunon in Q3 2021 and has held it in 2 quarters since.
  • 37 funds tracked by Wall St. Rank held Imunon as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.